Colorectal cancer (CRC) is still one of the most common types of cancer in the world, and
the gut microbiome plays an important role in its development. The microbiome is involved …

Colorectal cancer (CRC) is the third most common cancer worldwide and the leading cause
of cancer-related deaths. Recently, several studies have demonstrated that gut microbiota …

Despite overall success, T cell checkpoint inhibitors for cancer treatment are still only
efficient in a minority of patients. Recently, intestinal microbiota was found to critically …

Background Colitis-associated cancer (CAC) is known to be a complex combination of tumor
cells, non-tumor cells and a large intestinal flora. The increasing role of intestinal flora in …

Background & Aims Irritable bowel syndrome (IBS) and inflammatory bowel diseases result
in a substantial reduction in quality of life and a considerable socioeconomic impact. In IBS …

As a pleiotropic cytokine, interleukin-6 (IL-6) not only regulates the cellular immune
response, but it also promotes tumor development by activating multiple carcinogenic …

Colorectal cancer (CRC) is a leading cause of cancer morbidity and mortality worldwide.
The etiology and pathogenesis of CRC remain unclear. A growing body of evidence …

There is wide evidence that CRC could be prevented by regular physical activity, keeping a
healthy body weight, and following a healthy and balanced diet. Many sporadic CRCs …

Colorectal cancer (CRC) is a dangerous form of cancer that affects the gastrointestinal tract.
It is a major global health concern, and the aggressive behavior of tumor cells makes it …

Individuals with inflammatory bowel disease are at high risk of developing colitis-associated
cancer; thus, strategies to inhibit disease progression should be investigated. The study …